Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Better genetic diagnostics in Ugandan breast cancer patients

Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA
Better genetic diagnostics in Ugandan breast cancer patients ( Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA )
29 May 2020

Cisplatin plus/minus veliparib in metastatic TNBC and/or germline BRCA-associated breast cancer

Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA
Cisplatin plus/minus veliparib in metastatic TNBC and/or germline BRCA-associated breast cancer ( Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA )
29 May 2020

Update from KAITLIN for high-risk HER2-positive early breast cancer

Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA
Update from KAITLIN for high-risk HER2-positive early breast cancer ( Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA )
29 May 2020

CARTITUDE-1: JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell therapy for r/r multiple myeloma

Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA
CARTITUDE-1: JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell therapy for r/r multiple myeloma ( Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA )
29 May 2020

Sym015 shows superior specificity compared to TKIs for NSCLC

Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA
Sym015 shows superior specificity compared to TKIs for NSCLC ( Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA )
29 May 2020

Brigatinib for NSCLC, latest research and overcoming complications

Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA
Brigatinib for NSCLC, latest research and overcoming complications ( Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA )
29 May 2020

ADAURA results: Adjuvant osimertinib for EGFRm non-small cell lung cancer

Prof Roy Herbst - Yale Cancer Center, New Haven, USA
ADAURA results: Adjuvant osimertinib for EGFRm non-small cell lung cancer ( Prof Roy Herbst - Yale Cancer Center, New Haven, USA )
29 May 2020

COVID-19: Treating breast cancer and the knock on effects of the coronavirus pandemic

Prof Stephen Johnston - Royal Marsden NHS Foundation Trust, London, UK
COVID-19: Treating breast cancer and the knock on effects of the coronavirus pandemic ( Prof Stephen Johnston - Royal Marsden NHS Foundation Trust, London, UK )
28 May 2020

Pembrolizumab plus chemotherapy for patients with metastatic triple-negative breast cancer

Dr Javier Cortés - IOB Institute of Oncology, Madrid and Barcelona, Spain
Pembrolizumab plus chemotherapy for patients with metastatic triple-negative breast cancer ( Dr Javier Cortés - IOB Institute of Oncology, Madrid and Barcelona, Spain )
27 May 2020

COM701 as a monotherapy and in combination with nivolumab for various advanced solid tumours

Dr. Ecaterina Dumbrava - MD Anderson Cancer Centre, Houston, USA
COM701 as a monotherapy and in combination with nivolumab for various advanced solid tumours ( Dr. Ecaterina Dumbrava - MD Anderson Cancer Centre, Houston, USA )
27 May 2020

Conducting Oncology Clinical Trials in Africa II: AC3T - Assessing, profiling, and building cancer clinical trial capacity in Africa

Daniel Seymour - BIO Ventures for Global Health, Seattle, USA
Conducting Oncology Clinical Trials in Africa II: AC3T - Assessing, profiling, and building cancer clinical trial capacity in Africa ( Daniel Seymour - BIO Ventures for Global Health, Seattle, USA )
27 May 2020

Perioperative use of NSAIDs reduces risk of early relapse in breast cancer

Dr Michael Retsky - Harvard T.H. Chan School of Public Health, Boston, USA
Perioperative use of NSAIDs reduces risk of early relapse in breast cancer ( Dr Michael Retsky - Harvard T.H. Chan School of Public Health, Boston, USA )
26 May 2020